Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy

Jiaoli Wang^{1

2}, Haoran Hu³, Haixia Du⁴, Man Luo², Yilan Cao³, Jiaping Xu³, Tianhang Chen⁴, Yilei Guo³, Qixiang Li³, Wen Chen³, Yifei Zhang⁵, Jin Han³, Haitong Wan^{1

4}

Affiliations

¹ Zhejiang Chinese Medical University, Hangzhou, China.
² Department of Respiratory Medicine, Hangzhou First People's Hospital, Hangzhou, China.
³ College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
⁴ College of Life Science, Zhejiang Chinese Medical University, Hangzhou, China.
⁵ Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

PMID: 36052129
PMCID: PMC9425066
DOI: 10.3389/fphar.2022.986640

Published Erratum

Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy

Jiaoli Wang et al. Front Pharmacol. 2022.

. 2022 Aug 16:13:986640.

doi: 10.3389/fphar.2022.986640. eCollection 2022.

Authors

Jiaoli Wang^{1

2}, Haoran Hu³, Haixia Du⁴, Man Luo², Yilan Cao³, Jiaping Xu³, Tianhang Chen⁴, Yilei Guo³, Qixiang Li³, Wen Chen³, Yifei Zhang⁵, Jin Han³, Haitong Wan^{1

4}

Affiliations

¹ Zhejiang Chinese Medical University, Hangzhou, China.
² Department of Respiratory Medicine, Hangzhou First People's Hospital, Hangzhou, China.
³ College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
⁴ College of Life Science, Zhejiang Chinese Medical University, Hangzhou, China.
⁵ Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

PMID: 36052129
PMCID: PMC9425066
DOI: 10.3389/fphar.2022.986640

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.852604.].

Keywords: Yinhuapinggan (YHPG); clinical efficacy; clinical trial; community-acquired drug-resistant bacterial pneumonia (CDBP); multidrug resistance; traditional Chinese medicine (TCM).

PubMed Disclaimer

Erratum for

Clinical Efficacy Protocol of Yinhuapinggan Granules: A Randomized, Double-Blind, Parallel, and Controlled Clinical Trial Program for the Intervention of Community-Acquired Drug-Resistant Bacterial Pneumonia as a Complementary Therapy.
Wang J, Hu H, Du H, Luo M, Cao Y, Xu J, Chen T, Guo Y, Li Q, Chen W, Zhang Y, Han J, Wan H. Wang J, et al. Front Pharmacol. 2022 Jun 30;13:852604. doi: 10.3389/fphar.2022.852604. eCollection 2022. Front Pharmacol. 2022. PMID: 35847015 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy

Affiliations

Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources